2025 North America Age-Related Mascular Degeneration Revenue Opportunities Report
Description
The 2025 North America Age-Related Mascular Degeneration Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Age-related Mascular Degeneration by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Age-related Macular Degeneration (AMD) market in North America are Regeneron Pharmaceuticals Inc., Novartis AG, Bayer AG, and F. Hoffmann-La Roche Ltd. Regeneron, a U.S.-based biotechnology company, is notable for its Eylea drug, a leading treatment for wet AMD, with significant clinical and manufacturing investments in North America. Novartis, headquartered in Switzerland but with key U.S. operations, is recognized for its Beovu (brolucizumab) anti-VEGF treatment, approved for wet AMD, and maintains a major pharmaceutical presence in East Hanover, NJ.
Bayer AG, a German multinational with strong operations in North America, is an important player collaborating with Regeneron internationally and actively involved in the AMD therapeutics market. F. Hoffmann-La Roche Ltd., another Swiss giant, holds a significant market share through its innovative retinal disease drugs and sustained research in retinal degenerative disorders. These companies lead the North American AMD market through drug development, extensive clinical trials, and commercialization efforts reflecting the region's status as the largest AMD market globally.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Age-related Mascular Degeneration by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Age-related Macular Degeneration (AMD) market in North America are Regeneron Pharmaceuticals Inc., Novartis AG, Bayer AG, and F. Hoffmann-La Roche Ltd. Regeneron, a U.S.-based biotechnology company, is notable for its Eylea drug, a leading treatment for wet AMD, with significant clinical and manufacturing investments in North America. Novartis, headquartered in Switzerland but with key U.S. operations, is recognized for its Beovu (brolucizumab) anti-VEGF treatment, approved for wet AMD, and maintains a major pharmaceutical presence in East Hanover, NJ.
Bayer AG, a German multinational with strong operations in North America, is an important player collaborating with Regeneron internationally and actively involved in the AMD therapeutics market. F. Hoffmann-La Roche Ltd., another Swiss giant, holds a significant market share through its innovative retinal disease drugs and sustained research in retinal degenerative disorders. These companies lead the North American AMD market through drug development, extensive clinical trials, and commercialization efforts reflecting the region's status as the largest AMD market globally.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
